Ask the Expert: Rakesh Popat answers your questions on multiple myeloma at EHA 2025

Tonton & Download Video Musik Gratis

🏠 Beranda
⬇ DOWNLOAD NOW
Kalau muncul iklan pop-up, tutup lalu klik tombol kembali

Download lagu Ask the Expert: Rakesh Popat answers your questions on multiple myeloma at EHA 2025 secara gratis hanya untuk keperluan promosi. Dukung artis favorit kamu dengan membeli musik original di iTunes atau platform resmi lainnya.

🎬 Download Lagu Lainnya

Sequencing bispecific antibodies and CAR-T in multiple myeloma Sequencing bispecific antibodies and CAR-T in multiple myeloma
Initial results of JNJ-79635322, a novel next-generation trispecific antibody, in R/R myeloma Initial results of JNJ-79635322, a novel next-generation trispecific antibody, in R/R myeloma
The Phase III Quintessential-2 trial of arlo-cel versus SoC in myeloma: trial in progress The Phase III Quintessential-2 trial of arlo-cel versus SoC in myeloma: trial in progress
Treating RRMM with Bispecific Antibodies | Rakesh Popat, PhD | EHA 2024 Treating RRMM with Bispecific Antibodies | Rakesh Popat, PhD | EHA 2024
Newly Diagnosed Multiple Myeloma: What’s Changing in 2025? | ASCO & EHA Newly Diagnosed Multiple Myeloma: What’s Changing in 2025? | ASCO & EHA
Using Real World Data in Myeloma to Improve Outcomes | Rakesh Popat, MD | EHA 2022 Using Real World Data in Myeloma to Improve Outcomes | Rakesh Popat, MD | EHA 2022
Real-World Evidence for Teclistamab in Myeloma | Dr. Rakesh Popat Shares #EHA2025 Insights Real-World Evidence for Teclistamab in Myeloma | Dr. Rakesh Popat Shares #EHA2025 Insights
Enhancing outcomes in multiple myeloma with immune-based strategies Enhancing outcomes in multiple myeloma with immune-based strategies